On the Nature of the Interactions That Govern COV-2 Mutants Escape from Neutralizing Antibodies

Area of Science:

• Virology
• Immunology
• Computational Biology

Background:

• Vaccines and therapeutic antibodies are key COVID-19 pandemic tools.
• Identifying effective antibodies against evolving SARS-CoV-2 variants is resource-intensive.
• Understanding mutation-driven antibody escape is crucial for developing broad-spectrum therapeutics.

Purpose of the Study:

• To develop and apply a computational tool for predicting SARS-CoV-2 variant antibody escape.
• To elucidate the structural basis of antibody escape mutations in Delta and Omicron variants.
• To reduce the time and resources needed for antibody screening and development.

Main Methods:

• Utilized a previously established computational tool for binding energy predictions.
• Applied the tool to analyze the impact of Delta and Omicron mutations on antibody binding.
• Correlated computational predictions with experimental observations of antibody escape.

Main Results:

• Computational binding energy predictions closely matched experimental antibody escape data.
• Provided structural explanations for observed escape tendencies of SARS-CoV-2 variants.
• Delineated molecular interaction differences between spike variants, receptors, and antibodies.

Conclusions:

• The computational tool effectively predicts antibody escape, accelerating therapeutic development.
• Structural insights into variant mutations aid in designing antibodies effective against diverse strains.
• Understanding molecular interactions is vital for distinguishing receptor binding from antibody evasion.